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Neonatal Hyperthyroidism Associated with Isolated 
Submandibular Sialadenitis: Is it Just a Coincidence?
Case Report
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Introduction
Suppurative disease of the salivary glands is uncommon
in childhood. The parotid gland is more commonly involved
and is usually followed by submandibular sialadenitis (1).
Isolated neonatal submandibular sialadenitis is very rare and
seen mostly in premature infants. Predisposing factors 
include prematurity, dehydration, anatomic abnormalities of
the oral cavity, calculi in salivary ducts, hematogenous 
spread of infection from the mother, long-term oro-gastric
tube feeding, and infection acquired by ingestion of 
contaminated formula (1).
Neonatal hyperthyroidism is also rare and mostly secondary
to maternal Graves' disease. The clinical findings include 
irritability, poor weight gain despite good appetite, tachycardia,
goiter and exophtalmus. Cardiomyopathy, congestive cardiac
failure, craniosynostosis and accelerated bone maturation may
develop if treatment is delayed or suboptimal (2). Several 
congenital abnormalities, including cardiac abnormalities, 
inguinal hernia, imperforate anus, have been reported in 
association with untreated maternal hyperthyroidism. However,
sialadenitis in association with neonatal hyperthyroidism has
not been reported (3). Here, we present a full-term newborn
with hyperthyroidism who developed isolated submandibular
sialadenitis in the first two weeks of life. 
Case Report
A male infant was born via spontaneous vaginal delivery
at term. His birth weight was 3147 g. His mother was 
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and was treated with propylthiouracil (PTU) throughout
pregnancy. While labor and delivery were uncomplicated,
mild dyspnea, attributed to laryngomalacia, was noted in
the early postnatal period. At age 14 days, a swelling 
developed in the left submandibular region. The mass was
firm and tender. The diagnosis of sialadenitis was made on
clinical grounds, and confirmed by CT scan that showed an
enlarged left submandibular gland with no calcification, but
with round areas of low attenuation which were likely to
represent a dilated submandibular duct. White blood cell 
count was 23 000/mm
3 with 51% neutrophils, 2% bands,
26% lymphocytes, 10% monocytes, 1% eosinophils. The
infant was admitted to a local hospital with a diagnosis of
submandibular sialoadenitis and was treated with IV antibiotics
(ceftriaxone 150 mg q12h). The submandibular mass 
showed a significant decrease in size in the first two days
of admission. The patient remained afebrile throughout his
hospital course and was discharged on oral amoxicillin,
which was continued for 7 more days. His blood cultures
were negative. 
During this outside hospital follow-up the thyroid gland
was noted to be diffusely enlarged in his CT scan (obtained
for sialadenitis) and thyroid function tests were obtained.
Initial serum thyroxine (T4) level was >21 μg/dL (normal 
7.0-13.5 μg/dL for newborns) and thyroid stimulating hor-
mone (TSH) was undetectable (normal 0.45–5.50 μIU/mL). 
The patient was 45 days old when referred to our 
center. His mother reported that he had jitteriness, difficulty
in sleeping and poor weight gain despite a voracious 
appetite. She also noted that he had been sleeping with
eyes open and having about 10 bowel movements a day.
On examination he was thin, alert and irritable, moderately
dehydrated. His weight was 3920 g (a weight gain of 17
g/day since birth). His pulse rate was 182/min. He had a 
staring look and mild proptosis. The thyroid gland was 
diffusely enlarged. Examination of other systems did not
reveal any noteworthy findings. 
Thyroid function tests at presentation showed a T4 level
of >24.9 μg/dL (normal 7-13.5) and an undetectable TSH 
level (normal 0.45-5.5 μIU/mL). Thyroid stimulating 
immunoglobulin index was 6.2 (normal <1.9). The diagnosis
of neonatal hyperthyroidism was made and the patient was
started on PTU 7.5 mg/kg/day and propranolol 2 mg/kg/day.
He also received Lugol's solution (1 drop q8h on the first
day of treatment) because of high risk for congestive heart
failure. A gradual but steady improvement was noted in the
subsequent days. After discharge, antithyroid treatment
was monitored by frequent clinical and biochemical 
assessments and was discontinued at age nine months.
Discussion
Isolated submandibular sialadenitis is a rare condition in
the newborn period. It is reported to occur as a late-onset
neonatal infection at a median age of 12 days (1). The 
etiology is unclear, but it is speculated that reduced saliva
flow due to anatomic abnormalities, calculi or dehydration
play a role. A local source for infection such as long-term
oro-gastric tube feeding, infection by ingestion of 
contaminated formula or hematogenous spread of infection
from the mother are also considered as possible etiological
factors (4). Prematurity has been reported as the main risk
factor, suggesting that the immaturity of the immune sys-
tem is also an important factor for this condition (5,6). 
No risk factors were present in our patient, except for
hyperthyroidism. Because there are some clinical conditions
in which both thyroid and salivary glands are affected, it is
plausible to argue that the association of submandibular 
sialadenitis and neonatal hyperthyroidism may be more
than a simple coincidence. 
Although rare, reports on salivary gland involvement in
patients with autoimmune thyroiditis or thyroid involvement
in Sjogren’s syndrome suggest that common mechanisms
may be operative in the development of thyroid and salivary
gland immune disease (7). It has been reported that both
glands share antigens, which could be responsible for the
association between Sjogren’s syndrome and autoimmune
thyroiditis  (8). However, our patient's age, his clinical 
presentation and his good response to systemic antibiotic
treatment, are findings which suggest that an acute 
suppurative infection, rather than a chronic inflammatory 
sialadenitis, may have had a role in the etiology of the 
sialadenitis.
The next possibility is that hyperthyroidism and/or the
autoantibodies causing Graves’ disease alter saliva flow
and/or content, which in turn increase the risk for sialadenitis.
It is known that hyperthyroidism may influence the salivary
gland functions. Koczor-Rozmus et al (9) reported up to
90% reduction in stimulated saliva volume. Saliva content is
also altered by hyperthyroidism. Ford et al (10) found that
the concentrations of total protein, calcium and lactate
dehydrogenase activity significantly decreased in 
hyperthyroid patients compared to the control group, and
improved following radioactive iodine treatment. Toft et al (11)
demonstrated that the inability to secrete the water-soluble
glycoprotein form of the ABO blood group antigens into 
saliva was significantly more common in patients with 
Graves' disease. This defect in secretion of ABO blood 
group antigens is associated with increased susceptibility
to infection and to asymptomatic carriage of some 
microorganisms. It is therefore conceivable that the 
changes in saliva content could increase the vulnerability to
infection in patients with hyperthyroidism.
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salivary content is not known. The salivary glands have the
capacity to uptake and concentrate iodide selectively and 
sialadenitis is the most frequent complication of 131I 
therapy for thyroid cancer (12). The iodine uptake is likely
due to the expression of a highly specialized iodide 
transporter, sodium iodide symporter (NIS) in the salivary
glands. NIS is a membrane protein that mediates active 
I- transport in several tissues, including salivary glands as
well as the thyroid gland, the stomach, the thymus and 
breast tissues (13). Thyrotropin receptor antibodies were
shown to be present in salivary glands in relatively higher
concentrations than the serum concentrations in patients
with autoimmune thyroid disease (14). It is possible that
these antibodies increase the iodide concentration in 
salivary glands by altering NIS expression, which, in turn, 
affects the amount or composition of the saliva. 
Finally, dehydration has been cited as a predisposing
factor in previously reported cases with submandibular 
sialadenitis. Our patient was moderately dehydrated at 
presentation. Subclinical dehydration may have developed
in the early neonatal period in our patient due to frequent
stools and may have led to a predisposition to stasis in the
salivary ducts. 
In conclusion, both sialadenitis and hyperthyroidism are
rare, but dangerous conditions for newborns. Hyperthyroidism
alters saliva composition, may cause dehydration and can
be a contributing factor in sialadenitis. It is known that, 
despite their limited ability to develop an immune response
and their consequent susceptibility to some infections, 
neonates have a relatively efficient immune system to 
protect them from some immune mediated disorders and
autoimmune syndromes. Hyperthyroidism is one of those
syndromes  (15). The possible role of hyperthyroidism in 
neonatal sialadenitis was discussed in this presentation.
This causal relationship needs to be further studied. 
Meanwhile, this relationship should be considered when a
newborn with hyperthyroidism develops an unexplained 
fever and/or submandibular mass.
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